These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14040543)

  • 21. Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE).
    Bardou-Jacquet E; Brissot P
    Hematol Oncol Clin North Am; 2014 Aug; 28(4):625-35, v. PubMed ID: 25064704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-H and associated proteins in patients with hemochromatosis.
    Beutler E; West C; Gelbart T
    Mol Med; 1997 Jun; 3(6):397-402. PubMed ID: 9234244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis of hemochromatosis.
    Piperno A
    Expert Opin Med Diagn; 2013 Mar; 7(2):161-77. PubMed ID: 23530886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Iron metabolism in hereditary hemochromatosis].
    Andreeva AP; Levina AA; Sattarova DA; Tsibul'skaia MM; Tokarev iuN
    Vrach Delo; 1989 Apr; (4):65-9. PubMed ID: 2756692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetics and physiopathology of hemochromatosis].
    Brissot P; Lainé F; Moirand R; Loréal O
    Rev Prat; 2000 May; 50(9):972-6. PubMed ID: 10865496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C
    Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.
    Adams P; Altes A; Brissot P; Butzeck B; Cabantchik I; Cançado R; Distante S; Evans P; Evans R; Ganz T; Girelli D; Hultcrantz R; McLaren G; Marris B; Milman N; Nemeth E; Nielsen P; Pineau B; Piperno A; Porto G; Prince D; Ryan J; Sanchez M; Santos P; Swinkels D; Teixeira E; Toska K; Vanclooster A; White D;
    Hepatol Int; 2018 Mar; 12(2):83-86. PubMed ID: 29589198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous hemochromatosis: a case of typical hemochromatosis caused by repeated transfusions of blood.
    NAY CP
    N Y State J Med; 1957 Sep; 57(18):3003-4. PubMed ID: 13464997
    [No Abstract]   [Full Text] [Related]  

  • 29. A strategy for cloning the hereditary hemochromatosis gene.
    Beutler E; Gelbart T; West C; Kuhl W; Lee P
    Blood Cells Mol Dis; 1995; 21(3):207-16. PubMed ID: 8673473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of hereditary hemochromatosis and pernicious anaemia].
    Attout H; Guez S; Sériès C
    Rev Med Interne; 2004 Oct; 25(10):759-61. PubMed ID: 15471603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Latent hemochromatosis and the treatment of familial idiopathic hemochromatosis].
    MATHIEU J
    Union Med Can; 1962 Jun; 91():615-9. PubMed ID: 14471136
    [No Abstract]   [Full Text] [Related]  

  • 32. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects.
    Bothwell TH; MacPhail AP
    Semin Hematol; 1998 Jan; 35(1):55-71. PubMed ID: 9460809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
    Adams PC
    Mol Genet Metab; 2000; 71(1-2):81-6. PubMed ID: 11001800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The new paradigm of neonatal hemochromatosis: fetal alloimmune hepatitis].
    Costaguta A; Alvarez F
    Arch Argent Pediatr; 2012; 110(3):237-43. PubMed ID: 22760751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting hereditary hemochromatosis: current concepts and progress.
    Yen AW; Fancher TL; Bowlus CL
    Am J Med; 2006 May; 119(5):391-9. PubMed ID: 16651049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
    Olynyk JK; St Pierre TG; Britton RS; Brunt EM; Bacon BR
    Am J Gastroenterol; 2005 Apr; 100(4):837-41. PubMed ID: 15784029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
    Bardou-Jacquet E; Ben Ali Z; Beaumont-Epinette MP; Loreal O; Jouanolle AM; Brissot P
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):143-54. PubMed ID: 24321703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies.
    Cézard C; Rabbind Singh A; Le Gac G; Gourlaouen I; Ferec C; Rochette J
    Blood Cells Mol Dis; 2014 Jan; 52(1):27-34. PubMed ID: 23953397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis.
    Broedbaek K; Poulsen HE; Weimann A; Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2009 Oct; 47(8):1230-3. PubMed ID: 19686840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of hemochromatosis.
    Smith LH
    West J Med; 1990 Sep; 153(3):296-308. PubMed ID: 2219895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.